* Professional Positions
* Education & Training
* Professional Positions
| Date | Title (Department) | Company/Laboratory | City (Country) | Research Project |
|---|---|---|---|---|
| January 2018-Present | HEAD OF PROJECT MANAGEMENT CUSTOMIZED BREEDING SERVICE |  | Laval (FRANCE) | / |
| August 2015-January 2018 | PROJECT MANAGER (Transgenic Services) | | Laval (FRANCE) | / |
| 2011-November 2014 | SCIENTIFIC DIRECTOR – HEAD OF HUMAN GENETICS DEPARTMENT |  | St-Hubert (CANADA) | / |
| 2012-November 2014 | SCIENTIFIC DIRECTOR - HEAD OF R&D DEPARTMENT, PRINCIPAL INVESTIGATOR OF A CLINICAL STUDY | | St-Hubert (CANADA) | « Pharmacogenetics of metformin in type 2 diabetes » |
| 2010-2011 | RESEARCH ASSOCIATE (mentor : Dr V. Blank) |   | Montréal (CANADA) | « Identification of Nrf3 transcription factor as a new regulator of adipogenesis » |
| 2005-2010 | POSTDOCTORAL FELLOW (mentor : Dr V. Blank) | | Montréal (CANADA) | « Role of Cap’n’Collar transcription factors in carcinogenesis » « Regulation of Maf proteins in human myometrium cells by proinflammatory cytokines » |
| 2005 | POSTDOCTORAL FELLOW (mentors : Dr N. Latruffe et Dr V. Nicolas-Francès) |  | Dijon (FRANCE) | « Phenotypic analysis of a thiolase B-deficient mouse model » |
* Education & Training
| Date | Training | Laboratory | City (Country) | Research Project |
|---|---|---|---|---|
| 2001-2004 | PHD STUDENT (mentors : Dr N. Latruffe & Dr V. Nicolas-Francès) | | Dijon (FRANCE) | « Study of thiolase A and B genes encoding for peroxisomal 3-ketoacyl-CoA thiolase activity: cloning, regulation and targeted disruption of the peroxisomal thiolase B gene in mouse » |
| 2000-2001 | MASTER INTERNSHIP (ranking: 2nd/28) (mentors : Dr N. Latruffe & Dr V. Nicolas-Francès) | | Dijon (FRANCE) | « Tissue expression of the peroxisomal 3-ketoacyl-CoA thiolase A and B in PARalpha-deficient mice » |
| Summer 1999 | BACHELOR STUDENT (mentors : Dr G. Delsol et Dr M. Allouche) |  | Toulouse (FRANCE) | « Apoptosis modulation in Jurkat cells overexpressing the wild-type ALK protein (ALK) or the oncogenic fusion protein (NPM-ALK) » |